| 000 | 01917nam a2200301 a 4500 | ||
|---|---|---|---|
| 005 | 20250914131012.0 | ||
| 008 | 030911s2003 xxua b 001 0 eng b | ||
| 020 |
_a1555812546 _cRM401.80 |
||
| 039 | 9 |
_a200409291413 _bzainol _c200311171042 _dzaleha _c200310141614 _dnor _c200310131256 _dnor _y09-11-2003 _zdiyana |
|
| 060 | _aQV350 | ||
| 090 | _aQV350.W223a 2003 | ||
| 100 | 1 | _aWalsh, Christopher | |
| 245 | 1 | 0 |
_aAntibiotics : _bactions, origins, resistance / _cby Christopher Walsh |
| 260 |
_aWashington : _bASM Press, _c2003 |
||
| 300 |
_ax, 335 p. : _bill. ; _c26 cm. |
||
| 504 | _aReferences : p. 297-328 | ||
| 505 | 0 | _aAntibiotics: initial concepts -- Introduction to major antibiotic classes and modes of action -- Antibiotics that act on cell wall biosynthesis -- Antibiotics that block bacterial protein biosynthesis -- Antibiotics that block DNA replication and repair: the quinolones -- Other targets of antibacterial drugs -- Natural and producer immunity versus acquired resistance -- Enzymatic destruction or modification of the antibiotic by resistant bacteria -- Antibiotic resistance by efflux pumps -- Antibiotic resistance by replacement or modification of the antibiotic target -- Regulation of antibiotic biosynthesis in producer organisms -- Polyketide antibiotic biosynthesis: assembly-line enzymology -- Enzymatic assembly lines for nonribosomal peptide antibiotics -- Biosynthesis of other classes of antibiotics -- New looks at targets -- New molecules -- Contexts and challenges for the use of new antibiotics | |
| 650 | 2 |
_aAntibiotics _xpharmacology |
|
| 650 | 2 | _aDrug Resistance, Bacterial | |
| 907 |
_a.b13258576 _b2019-11-12 _c2019-11-12 |
||
| 942 |
_c01 _n0 _kQV350.W223a 2003 |
||
| 914 | _avtls000340340 | ||
| 990 | _adh | ||
| 991 | _aJabatan Makmal Diagnostik, HUKM | ||
| 991 | _aJabatan Farmasi | ||
| 998 |
_ad _ah _b2003-11-09 _cm _da _feng _gxxu _y0 _z.b13258576 |
||
| 999 |
_c325362 _d325362 |
||